FAM62B Activators encompass a variety of chemical compounds that enhance the functional activity of FAM62B through distinct signaling pathways. Forskolin and IBMX are particularly effective in raising intracellular cAMP levels, thereby activating PKA which can phosphorylate and activate FAM62B. Similarly, dibutyryl-cAMP, as a cAMP analog, activates PKA and is presumed to have a direct positive effect on FAM62B's phosphorylation and activity. Phorbol 12-myristate 13-acetate (PMA) and Anisomycin activate PKC and SAPK/JNK, respectively, which can lead to phosphorylation events that promote FAM62B's activity, potentially by altering its conformation or interaction with other proteins. Ionomycin and A23187, both calcium ionophores, increase intracellular calcium, which can activate calcium-dependent kinases capable of enhancing FAM62B activity either through direct phosphorylation or through modulation of associated signaling pathways.
In addition to these activators thatoperate through kinase signaling, compounds like Retinoic acid and Epidermal Growth Factor (EGF) can indirectly enhance FAM62B's activity through gene regulatory mechanisms and initiation of kinase cascades. Retinoic acid may upregulate proteins that interact with FAM62B, while EGF activates the EGFR pathway, potentially influencing FAM62B's role in the cell. Insulin signaling, which triggers the PI3K/AKT pathway, is known for its broad regulatory functions, and it could enhance FAM62B function through a similar mechanism, likely involving alterations in phosphorylation patterns or protein-protein interactions. Moreover, Okadaic acid and Calyculin A, as inhibitors of protein phosphatases, lead to a general increase in protein phosphorylation, which may result in the enhanced activity of FAM62B due to reduced dephosphorylation rates. The collective action of these FAM62B activators, through targeted effects on signaling pathways and phosphorylation states, serve to potentiate the function of FAM62B without directly upregulating its expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which can activate calcium-dependent protein kinases. These kinases may then influence FAM62B function by phosphorylating it or associated proteins, thereby enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate a range of target proteins. PKC-mediated phosphorylation of proteins in the pathway where FAM62B is involved may lead to its enhanced activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression through its receptor. It may enhance the functional activity of FAM62B by promoting the expression of proteins that interact with or modify FAM62B, thereby indirectly enhancing its activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation leads to a cascade that can activate PI3K/AKT signaling pathway, which is known to regulate a wide array of cellular functions. This pathway could enhance FAM62B activity by phosphorylation or by altering its interaction with other cellular proteins. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels that can activate PKA. This, in turn, might enhance the phosphorylation and activity of FAM62B. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that can increase intracellular calcium levels, thereby activating calmodulin-dependent kinases, which could potentially enhance the phosphorylation state and activity of FAM62B. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates PKA. The activation of PKA may enhance the phosphorylation and activity of FAM62B. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of many proteins. This could indirectly enhance the activity of FAM62B if it is regulated by dephosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as an activator of stress-activated protein kinases (SAPKs/JNKs). SAPK/JNK signaling may modify FAM62B activity through phosphorylation or by influencing the cellular stress response pathways in which FAM62B may play a role. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases like okadaic acid and may have similar effects in terms of enhancing the phosphorylation state and thus the activity of FAM62B. | ||||||